Mechanism of cardioprotection following trauma-hemorrhagic shock by a selective estrogen receptor-beta agonist: up-regulation of cardiac heat shock factor-1 and heat shock proteins

J Mol Cell Cardiol. 2006 Jan;40(1):185-94. doi: 10.1016/j.yjmcc.2005.10.001. Epub 2005 Nov 8.

Abstract

Although 17beta-estradiol (E2) administration following trauma-hemorrhage (T-H) improves cardiac function in male rodents, it is not known whether the salutary effects of E2 are mediated via estrogen receptor (ER)-alpha or ER-beta, and whether cardiac heat shock proteins (Hsp) are affected by E2 administration. Male Sprague-Dawley rats underwent T-H (mean BP 40 mmHg for 90 min, then resuscitation). ER-alpha agonist propyl pyrazole triol (PPT) (5 microg/kg), ER-beta agonist diarylpropiolnitrile (DPN) (5 microg/kg), or vehicle (10% DMSO) was injected subcutaneously during resuscitation. At 24 h after T-H or sham operation, cardiac output (CO), stroke volume (SV), mean blood pressure, and +/- dP/dt max were measured (n=6 rats per group). Cardiac Hsp32, 60, 70, and 90 mRNA/protein expressions and heat shock factor (HSF)-1 DNA binding activity were determined. One-way ANOVA and Tukey's test were used for statistical analysis. CO, SV and +/- dP/dt(max) decreased significantly after T-H, however, administration of ER-beta agonist DPN after T-H restored the above parameters. Moreover, DPN treatment prevented T-H-mediated decrease in Hsp60 mRNA/protein and Hsp90 protein expressions in the heart. Hsp32 and Hsp70 mRNA/protein expression and HSF-1 DNA binding activity in the hearts were increased even above the shams in DPN treated T-H rats. In contrast, no significant change in the above parameters was observed in T-H rats treated with ER-alpha agonist PPT. Thus, the salutary effects of E2 on cardiac function are mediated via ER-beta and ER-beta-induced up-regulation of Hsp likely plays a significant role in the E2-mediated cardioprotection after T-H.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Animals
  • DNA-Binding Proteins / drug effects*
  • DNA-Binding Proteins / metabolism
  • Estradiol / analogs & derivatives
  • Estradiol / pharmacology
  • Estrogen Receptor alpha / agonists
  • Estrogen Receptor beta / agonists*
  • Fulvestrant
  • Heat Shock Transcription Factors
  • Heat-Shock Proteins / drug effects*
  • Heat-Shock Proteins / metabolism
  • Male
  • Myocardium / metabolism
  • Nitriles / pharmacology*
  • Phenols
  • Propionates / pharmacology*
  • Protective Agents / pharmacology*
  • Pyrazoles / pharmacology
  • Rats
  • Rats, Sprague-Dawley
  • Selective Estrogen Receptor Modulators / pharmacology
  • Shock, Hemorrhagic / drug therapy
  • Shock, Hemorrhagic / metabolism*
  • Transcription Factors / drug effects*
  • Transcription Factors / metabolism
  • Up-Regulation
  • Wounds and Injuries / complications
  • Wounds and Injuries / metabolism

Substances

  • 2,3-bis(4-hydroxyphenyl)-propionitrile
  • DNA-Binding Proteins
  • Estrogen Receptor alpha
  • Estrogen Receptor beta
  • Heat Shock Transcription Factors
  • Heat-Shock Proteins
  • Nitriles
  • Phenols
  • Propionates
  • Protective Agents
  • Pyrazoles
  • Selective Estrogen Receptor Modulators
  • Transcription Factors
  • 4,4',4''-(4-propyl-((1)H)-pyrazole-1,3,5-triyl) tris-phenol
  • Fulvestrant
  • Estradiol